Venus Medtech (Hangzhou), Inc. Class H (2500) Income Statement

Last quarter (Q2 2024), Venus Medtech (Hangzhou), Inc. Class H's total revenue was ¥230.72M, an increase of 80.53% from the same quarter last year. In Q2, Venus Medtech (Hangzhou), Inc. Class H's net income was ¥-206.49M. See Venus Medtech (Hangzhou), Inc. Class H’s key income statements, including revenue, expenses, profit, and income.